Skip to main content

Fingolimod alters inflammatory mediators and vascular permeability in intracerebral hemorrhage

Neuroscience Bulletin volume 31, pages 755–762 (2015)Cite this article

Abstract

Intracerebral hemorrhage (ICH) leads to high rates of death and disability. The pronounced inflammatory reactions that rapidly follow ICH contribute to disease progression. Our recent clinical trial demonstrated that oral administration of an immune modulator fingolimod restrained secondary injury derived from initial hematoma, but the mechanisms remain unknown. In this study, we aim to investigate the effects of fingolimod on inflammatory mediators and vascular permeability in the clinical trial of oral fingolimod for intracerebral hemorrhage (ICH). The results showed that fingolimod decreased the numbers of circulating CD4+ T, CD8+ T, CD19+ B, NK, and NKT cells and they recovered quickly after the drug was stopped. The plasma ICAM level was decreased and IL-10 was increased by fingolimod. Interestingly, fingolimod protected vascular permeability as indicated by a decreased plasma level of MMP9 and the reduced rT1%. In conclusion, modulation of systemic inflammation by fingolimod demonstrates that it is an effective therapeutic agent for ICH. Fingolimod may prevent perihematomal edema enlargement by protecting vascular permeability.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet 2009, 373: 1632–1644.

    PubMed Central  Article  PubMed  Google Scholar 

  2. Ribo M, Grotta JC. Latest advances in intracerebral hemorrhage. Curr Neurol Neurosci Rep 2006, 6: 17–22.

    Article  PubMed  Google Scholar 

  3. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010, 9: 167–176.

    Article  PubMed  Google Scholar 

  4. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med 2001, 344: 1450–1460.

    CAS  Article  PubMed  Google Scholar 

  5. Wang J. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol 2010, 92: 463–477.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  6. Mracsko E, Veltkamp R. Neuroinflammation after intracerebral hemorrhage. Front Cell Neurosci 2014, 8: 388.

    PubMed Central  Article  PubMed  Google Scholar 

  7. Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol 2012, 11: 720–731.

    CAS  Article  PubMed  Google Scholar 

  8. Fu Y, Hao J, Zhang N, Ren L, Sun N, Li YJ, et al. Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proofof- concept study. JAMA Neurol 2014, 71: 1092–1101.

    Article  PubMed  Google Scholar 

  9. Kim JY, Kawabori M, Yenari MA. Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets. Curr Med Chem 2014, 21: 2076–2097.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  10. Zhou Y, Wang Y, Wang J, Anne Stetler R, Yang QW. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol 2014, 115: 25–44.

    CAS  Article  PubMed  Google Scholar 

  11. Fang H, Wang PF, Zhou Y, Wang YC, Yang QW. Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury. J Neuroinflammation 2013, 10: 27.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  12. Moxon-Emre I, Schlichter LC. Neutrophil depletion reduces blood-brain barrier breakdown, axon injury, and inflammation after intracerebral hemorrhage. J Neuropathol Exp Neurol 2011, 70: 218–235.

    CAS  Article  PubMed  Google Scholar 

  13. Aronowski J, Hall CE. New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies. Neurol Res 2005, 27: 268–279.

    Article  PubMed  Google Scholar 

  14. Gao Z, Wang J, Thiex R, Rogove AD, Heppner FL, Tsirka SE. Microglial activation and intracerebral hemorrhage. Acta Neurochir Suppl 2008, 105: 51–53.

    CAS  Article  PubMed  Google Scholar 

  15. Hickenbottom SL, Grotta JC, Strong R, Denner LA, Aronowski J. Nuclear factor-kappaB and cell death after experimental intracerebral hemorrhage in rats. Stroke 1999, 30: 2472–2477; discussion 2477–2478.

    CAS  Article  PubMed  Google Scholar 

  16. Wang J, Dore S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 2007, 27: 894–908.

    CAS  Article  PubMed  Google Scholar 

  17. Guo FQ, Li XJ, Chen LY, Yang H, Dai HY, Wei YS, et al. Study of relationship between inflammatory response and apoptosis in perihematoma region in patients with intracerebral hemorrhage. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2006, 18: 290–293.

    CAS  PubMed  Google Scholar 

  18. Liesz A, Ruger H, Purrucker J, Zorn M, Dalpke A, Mohlenbruch M, et al. Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases. PLoS One 2013, 8: e74839.

    Article  Google Scholar 

  19. Shah IM, Macrae IM, Di Napoli M. Neuroinflammation and neuroprotective strategies in acute ischaemic stroke - from bench to bedside. Curr Mol Med 2009, 9: 336–354.

    CAS  Article  PubMed  Google Scholar 

  20. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol 2007, 184: 53–68.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  21. Rolland WB, Lekic T, Krafft PR, Hasegawa Y, Altay O, Hartman R, et al. Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage. Exp Neurol 2013, 241: 45–55.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  22. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994, 8: 504–512.

    CAS  PubMed  Google Scholar 

  23. Dziedzic T, Bartus S, Klimkowicz A, Motyl M, Slowik A, Szczudlik A. Intracerebral hemorrhage triggers interleukin-6 and interleukin-10 release in blood. Stroke 2002, 33: 2334–2335.

    CAS  Article  PubMed  Google Scholar 

  24. Weng JC, Wu SK, Lin WL, Tseng WY. Detecting bloodbrain barrier disruption within minimal hemorrhage following transcranial focused ultrasound: a correlation study with contrast-enhanced MRI. Magn Reson Med 2011, 65: 802–811.

    Article  PubMed  Google Scholar 

  25. Barr TL, Latour LL, Lee KY, Schaewe TJ, Luby M, Chang GS, et al. Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. Stroke 2010, 41: e123–128.

    Article  Google Scholar 

  26. Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, Davalos A, et al. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke 2005, 36: 86–91.

    Article  PubMed  Google Scholar 

  27. Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M. Collagenase-induced intracerebral hemorrhage in rats. Stroke 1990, 21: 801–807.

    CAS  Article  PubMed  Google Scholar 

  28. Heo JH, Lucero J, Abumiya T, Koziol JA, Copeland BR, del Zoppo GJ. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 1999, 19: 624–633.

    CAS  Article  PubMed  Google Scholar 

  29. Abilleira S, Montaner J, Molina CA, Monasterio J, Castillo J, Alvarez-Sabin J. Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. J Neurosurg 2003, 99: 65–70.

    CAS  Article  PubMed  Google Scholar 

  30. Yong VW. Metalloprote inases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 2005, 6: 931–944.

    CAS  Article  PubMed  Google Scholar 

  31. Sun C, Wang Q, Zhou H, Yu S, Simard AR, Kang C, et al. Antisense MMP-9 RNA inhibits malignant glioma cell growth in vitro and in vivo. Neurosci Bull 2013, 29: 83–93.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, 300052, China

    Yu-Jing Li, Guo-Qiang Chang, Yuanchu Liu, Ye Gong, Chunsheng Yang, Fu-Dong Shi, Ying Fu & Yaping Yan

  2. Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, College of Life Sciences, Shaanxi Normal University, Xi’an, 710062, China

    Yuanchu Liu & Ye Gong

  3. Department of Neurology, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, 85013, USA

    Kristofer Wood & Fu-Dong Shi

Authors
  1. Yu-Jing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guo-Qiang Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuanchu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ye Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chunsheng Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kristofer Wood
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fu-Dong Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ying Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yaping Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Ying Fu or Yaping Yan.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Li, YJ., Chang, GQ., Liu, Y. et al. Fingolimod alters inflammatory mediators and vascular permeability in intracerebral hemorrhage. Neurosci. Bull. 31, 755–762 (2015). https://doi.org/10.1007/s12264-015-1532-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-015-1532-2

Keywords

  • fingolimod
  • inflammatory mediator
  • vascular permeability
  • intracerebral hemorrhage